Long-Term Proactive Management of Psoriasis Vulgaris with Fixed-Dose Combination of Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Foam: Results from a Phase III Randomized Controlled Trial. (2020). SKIN The Journal of Cutaneous Medicine, 4(5), s32. https://doi.org/10.25251/skin.4.supp.32